Vitiligo Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• You are able to read and sign a consent form agreeing to take part in the study.
• You are between 18 and 60 years old (men and women are both eligible).
• You have been diagnosed with non-segmental vitiligo (the type that can appear on both sides of the body, rather than only one side).
• Your vitiligo patches are in areas that are relatively flat and not on the hands, feet, groin, lips, joints, or area around the anus, and the total affected skin area covers 30% or less of your body.
• Your vitiligo has been stable for more than one year, meaning no existing patches have grown larger and no new patches have appeared.
• If you are a woman who could become pregnant, you must be willing to use at least one highly effective form of birth control from the time you sign consent until your final study visit.
• You are willing and able to attend all scheduled appointments, follow the treatment plan, and complete all required tests and procedures.

Who may not be able to join:

• You currently have another active skin condition (such as psoriasis or dermatitis) or a skin infection that could make it harder to assess your vitiligo.
• You had a serious infection requiring hospital treatment with antibiotics or antiviral/antifungal medicines in the month before screening, or you are currently being treated for an infection.
• You have tested positive for Hepatitis B, Hepatitis C, HIV, or syphilis.
• You currently have active tuberculosis (TB), are being treated for TB, or have received TB treatment within the past year.
• Your liver is not functioning normally based on blood tests taken at screening.
• Your kidneys are not functioning well enough, or you are currently on dialysis.
• You have or have had cancer, with the exception of certain non-spreading skin cancers that have been fully treated or removed.
• You currently have a thyroid condition or are taking thyroid replacement medication.
• You have a history of a mental health condition such as anxiety or depression that the study doctor feels would make it unsafe for you to participate.
• You are currently pregnant or breastfeeding.
• You have had laser treatment or light therapy for vitiligo in the 4 weeks before the study start date.
• You have taken any oral or whole-body medicines aimed at treating vitiligo (such as steroids, cyclosporine, methotrexate, tacrolimus, or certain traditional medicines) in the 4 weeks before the study start date.
• You have taken a type of medication called a JAK inhibitor (such as ruxolitinib or tofacitinib) within approximately 12 weeks before the study start date (confirm with trial site for exact timing).
• You have received a biologic medicine (a type of treatment made from living cells) within approximately 12 weeks before the study start date (confirm with trial site for exact timing).
• You have taken part in another clinical trial involving an investigational treatment within 4 weeks before the study start date, or the last dose of that treatment has not fully cleared your body yet.
• The study doctor has any other reason to believe it would not be appropriate for you to join the trial.

Important: Always verify eligibility with the trial site directly before applying.